Department of Cardiovascular Surgery, Hospital Clínico, University of Barcelona, Barcelona, Spain.
Eur J Cardiothorac Surg. 2013 Nov;44(5):e325-31. doi: 10.1093/ejcts/ezt374. Epub 2013 Aug 4.
Patients with thoracic aneurysmal disease involving the arch and the descending or thoracoabdominal aorta may require more than one surgical intervention. The results of one-stage repair using a hybrid stent-graft in the frozen elephant trunk manner are presented.
Between January 2005 and March 2012, 113 (age 67 ± 10 years) of 358 registered patients in the International E-Vita Open Registry were operated on for combined arch and descending and thoracoabdominal aortic aneurysm. Thirty-one (27%) patients had a previous cardiothoracic, abdominal aortic surgery or endovascular repair. The E-Vita Open hybrid stent-graft was used in all cases. Postoperatively and during the follow-up (100%), aortic image examinations were performed.
Combined arch replacement and antegrade stent-grafting distally (graft diameter 34 ± 4 mm) were performed under selective cerebral perfusion (72 ± 27 min) and hypothermic visceral ischaemia (65 ± 27 min). Postoperatively, aneurysm exclusion was completely and partially achieved in 80% and 20%, respectively. In-hospital mortality and survival rate after 5 years were 12% (13 of 113) and 78%, respectively. Latest aortic imaging demonstrated 93% complete aneurysm exclusion. Freedom from secondary endovascular intervention and open surgery were 88 and 90%, respectively.
In multisegmental thoracic aneurysmal disease, combined arch replacement with distal repair by a hybrid stent-graft enables one-stage treatment with acceptable mortality. Aneurysm exclusion by the stent-graft seems to be primarily curative and allows easier access for distal open or endovascular reintervention.
涉及主动脉弓和降主动脉或胸腹主动脉的胸动脉瘤患者可能需要多次手术干预。本文介绍了采用杂交支架移植物行冷冻象鼻技术一期修复的结果。
2005 年 1 月至 2012 年 3 月,国际 E-Vita Open 注册中心登记的 358 例胸主动脉瘤患者中有 113 例(年龄 67 ± 10 岁)接受了联合主动脉弓和降主动脉及胸腹主动脉瘤的手术治疗。31 例(27%)患者既往有心胸、腹主动脉手术或血管内修复史。所有患者均使用 E-Vita Open 杂交支架移植物。术后及随访期间(100%)均进行主动脉影像检查。
选择性脑灌注(72 ± 27 min)和低温内脏缺血(65 ± 27 min)下完成联合主动脉弓置换和顺行支架移植物置入(移植物直径 34 ± 4 mm)。术后完全和部分动脉瘤隔绝分别为 80%和 20%。院内死亡率和 5 年生存率分别为 12%(13/113)和 78%。最新的主动脉影像学检查显示 93%完全排除了动脉瘤。二期血管内和开放手术的无再干预率分别为 88%和 90%。
在多节段胸主动脉瘤病中,采用杂交支架移植物行联合主动脉弓置换和远端修复可进行一期治疗,死亡率可接受。支架移植物的动脉瘤隔绝似乎是主要的治愈性方法,并且为远端开放或血管内再干预提供了更方便的途径。